WO2007017585A3 - Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
WO2007017585A3
WO2007017585A3 PCT/FR2006/001901 FR2006001901W WO2007017585A3 WO 2007017585 A3 WO2007017585 A3 WO 2007017585A3 FR 2006001901 W FR2006001901 W FR 2006001901W WO 2007017585 A3 WO2007017585 A3 WO 2007017585A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
camptothecin analogues
Prior art date
Application number
PCT/FR2006/001901
Other languages
English (en)
Other versions
WO2007017585A2 (fr
Inventor
Gilbert Lavielle
Patrick Hautefaye
Alain Pierre
John Hickman
Stephane Leonce
Original Assignee
Servier Lab
Gilbert Lavielle
Patrick Hautefaye
Alain Pierre
John Hickman
Stephane Leonce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Gilbert Lavielle, Patrick Hautefaye, Alain Pierre, John Hickman, Stephane Leonce filed Critical Servier Lab
Priority to EA200800393A priority Critical patent/EA014689B1/ru
Priority to MX2008001560A priority patent/MX2008001560A/es
Priority to AU2006277863A priority patent/AU2006277863A1/en
Priority to EP06794288A priority patent/EP1910377A2/fr
Priority to JP2008524549A priority patent/JP2009503039A/ja
Priority to BRPI0614608A priority patent/BRPI0614608A2/pt
Priority to US11/990,065 priority patent/US20100168149A1/en
Priority to CA2617957A priority patent/CA2617957C/fr
Publication of WO2007017585A2 publication Critical patent/WO2007017585A2/fr
Publication of WO2007017585A3 publication Critical patent/WO2007017585A3/fr
Priority to NO20081169A priority patent/NO20081169L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Abstract

Composé de formule (I) (I) dans laquelle : • R1, R2, R3, R4, R5, R80, R90, R81, R91, AIk et G sont tels que définis dans la description. Médicaments.
PCT/FR2006/001901 2005-08-05 2006-08-04 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent WO2007017585A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EA200800393A EA014689B1 (ru) 2005-08-05 2006-08-04 Новые соединения - аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
MX2008001560A MX2008001560A (es) 2005-08-05 2006-08-04 Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AU2006277863A AU2006277863A1 (en) 2005-08-05 2006-08-04 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
EP06794288A EP1910377A2 (fr) 2005-08-05 2006-08-04 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2008524549A JP2009503039A (ja) 2005-08-05 2006-08-04 新規カンプトセシン類似体化合物、その製造法、および該化合物を含有する薬学的組成物
BRPI0614608A BRPI0614608A2 (pt) 2005-08-05 2006-08-04 análogos de camptotecina, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os ditos compostos
US11/990,065 US20100168149A1 (en) 2005-08-05 2006-08-04 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
CA2617957A CA2617957C (fr) 2005-08-05 2006-08-04 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO20081169A NO20081169L (no) 2005-08-05 2008-03-05 Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508364 2005-08-05
FR0508364A FR2889527A1 (fr) 2005-08-05 2005-08-05 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
WO2007017585A2 WO2007017585A2 (fr) 2007-02-15
WO2007017585A3 true WO2007017585A3 (fr) 2007-04-12

Family

ID=36216903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2006/001901 WO2007017585A2 (fr) 2005-08-05 2006-08-04 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (19)

Country Link
US (1) US20100168149A1 (fr)
EP (1) EP1910377A2 (fr)
JP (1) JP2009503039A (fr)
KR (1) KR20080032007A (fr)
CN (1) CN101238133A (fr)
AR (1) AR056189A1 (fr)
AU (1) AU2006277863A1 (fr)
BR (1) BRPI0614608A2 (fr)
CA (1) CA2617957C (fr)
EA (1) EA014689B1 (fr)
FR (1) FR2889527A1 (fr)
GE (1) GEP20115243B (fr)
MA (1) MA29653B1 (fr)
MX (1) MX2008001560A (fr)
MY (1) MY150497A (fr)
NO (1) NO20081169L (fr)
UA (1) UA95253C2 (fr)
WO (1) WO2007017585A2 (fr)
ZA (1) ZA200801991B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889528B1 (fr) * 2005-08-05 2007-09-07 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2014127214A1 (fr) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Composés thérapeutiques et utilisations de ceux-ci
AU2014219024B2 (en) 2013-02-20 2018-04-05 KALA BIO, Inc. Therapeutic compounds and uses thereof
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
AU2014342042B2 (en) 2013-11-01 2017-08-17 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN106188079A (zh) * 2016-07-09 2016-12-07 兰州大学 喜树碱7‑位哌嗪硫脲类化合物、制备方法和用途
CA3036336A1 (fr) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Formes cristallines de composes therapeutiques et leurs utilisations
US10392399B2 (en) 2016-09-08 2019-08-27 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
BR112019004463A2 (pt) 2016-09-08 2019-05-28 Kala Pharmaceuticals Inc formas cristalinas de compostos terapêuticos, seus processos de obtenção e seus métodos de uso
CN110357897A (zh) * 2019-07-26 2019-10-22 上海健康医学院 一种具有抗肿瘤活性的喜树碱衍生物及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1101765A2 (fr) * 1999-11-18 2001-05-23 Adir Et Compagnie Nouveaux composés analogues de la camptothécine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US20030105109A1 (en) * 1999-11-18 2003-06-05 Gilbert Lavielle New campothecin analogue compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6111107A (en) * 1997-11-20 2000-08-29 Enzon, Inc. High yield method for stereoselective acylation of tertiary alcohols
US6403604B1 (en) * 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
AU2003243380A1 (en) * 2002-06-03 2003-12-19 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
CN100443486C (zh) * 2002-09-11 2008-12-17 中国医学科学院药物研究所 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
FR2889528B1 (fr) * 2005-08-05 2007-09-07 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1101765A2 (fr) * 1999-11-18 2001-05-23 Adir Et Compagnie Nouveaux composés analogues de la camptothécine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US20030105109A1 (en) * 1999-11-18 2003-06-05 Gilbert Lavielle New campothecin analogue compounds

Also Published As

Publication number Publication date
MY150497A (en) 2014-01-30
EP1910377A2 (fr) 2008-04-16
JP2009503039A (ja) 2009-01-29
AU2006277863A1 (en) 2007-02-15
AR056189A1 (es) 2007-09-26
FR2889527A1 (fr) 2007-02-09
BRPI0614608A2 (pt) 2016-11-16
EA200800393A1 (ru) 2008-08-29
CA2617957C (fr) 2011-09-20
KR20080032007A (ko) 2008-04-11
CN101238133A (zh) 2008-08-06
EA014689B1 (ru) 2010-12-30
MX2008001560A (es) 2008-02-15
GEP20115243B (en) 2011-06-27
WO2007017585A2 (fr) 2007-02-15
UA95253C2 (ru) 2011-07-25
NO20081169L (no) 2008-03-05
ZA200801991B (en) 2009-08-26
CA2617957A1 (fr) 2007-02-15
MA29653B1 (fr) 2008-07-01
US20100168149A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
WO2007017585A3 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ME01400B (fr) Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2006025979A3 (fr) Modulateurs de recepteurs nucleaires
PT1753712E (pt) Derivados de amino-propanol
WO2008006715A3 (fr) Compositions pharmaceutiques améliorées
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
WO2008120725A1 (fr) Nouveau dérivé de pyrrolinone et composition médicale le contenant
WO2006117211A3 (fr) Derives d'uree, procedes pour leur fabrication et utilisations de ces derives
WO2009007535A3 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
TW200730510A (en) Chroman compounds
DK1869038T3 (da) Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
IL186062A (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
WO2007068728A3 (fr) Pyrrolopyridinones n-substituees actives en tant qu'inhibiteurs de kinase
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
WO2008073863A3 (fr) Préparation et utilité d'allylamines substituées
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
IL176993A0 (en) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
WO2006090265A3 (fr) Procedes de preparation de levetiracetam, son intermediaire et utilisation de levetiracetam dans des compositions pharmaceutiques
WO2007001225A8 (fr) Modulateurs d'alpha 7
GEP20115229B (en) Novel camptothecin analogues compounds, a method for preparation thereof and pharmaceutical compositions containing them
WO2011070253A8 (fr) Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007206876B2 (en) Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006794288

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 565395

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/001560

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 200680028657.2

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2006277863

Country of ref document: AU

Ref document number: 2617957

Country of ref document: CA

Ref document number: 2008020199

Country of ref document: EG

WWE Wipo information: entry into national phase

Ref document number: 2008524549

Country of ref document: JP

Ref document number: 11990065

Country of ref document: US

Ref document number: 1011/DELNP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 200800393

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 10531

Country of ref document: GE

ENP Entry into the national phase

Ref document number: 2006277863

Country of ref document: AU

Date of ref document: 20060804

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006277863

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087005342

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2006794288

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0614608

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080201